Your browser doesn't support javascript.
loading
Oxymatrine relieves high-fructose/fat-induced obesity via reprogramming the activity of lipid metabolism-related enhancer.
Ren, Luping; Liu, Xuehua; Huang, Xitong; Zhang, He; Fei, Wenjie; Yu, Xian; Hu, Zhijuan; Zhen, Yunfeng; Chen, Shuchun.
Afiliação
  • Ren L; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Liu X; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Huang X; Graduate School of Hebei North University, Zhangjiakou, Hebei, China.
  • Zhang H; Department of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing, Jiangsu, China.
  • Fei W; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Yu X; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Hu Z; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Zhen Y; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Chen S; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, China.
Front Endocrinol (Lausanne) ; 14: 1145575, 2023.
Article em En | MEDLINE | ID: mdl-37600712

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metabolismo dos Lipídeos / Hepatopatia Gordurosa não Alcoólica Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metabolismo dos Lipídeos / Hepatopatia Gordurosa não Alcoólica Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China